In conclusion, our results suggest that 5-year overall survival in sarcoma cases with negative E-cadherin expression is worse than in sarcoma cases with positive E-cadherin expression, particularly in synovial sarcoma, osteosarcoma and leiomyosarcoma cases. This evidence concerns the gene CDH1 and sarcoma.